Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Omega-3 and omega-6 fatty acids have distinct effects on endothelial fatty acid content and nitric oxide bioavailability
Samuel Sherratt, Hazem Dawoud, Deepak L. Bhatt, et al.
Prostaglandins Leukotrienes and Essential Fatty Acids (2021) Vol. 173, pp. 102337-102337
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Role of Omega-3 Fatty Acids in Cardiovascular Disease: the Debate Continues
Samuel Sherratt, Peter Libby, Matthew J. Budoff, et al.
Current Atherosclerosis Reports (2022) Vol. 25, Iss. 1, pp. 1-17
Open Access | Times Cited: 77
Prevention of Cardiovascular Events and Mortality With Icosapent Ethyl in Patients With Prior Myocardial Infarction
Prakriti Gaba, Deepak L. Bhatt, Philippe Gabríel Steg, et al.
Journal of the American College of Cardiology (2022) Vol. 79, Iss. 17, pp. 1660-1671
Open Access | Times Cited: 48
The Effects of Omega 3 and Omega 6 Fatty Acids on Glucose Metabolism: An Updated Review
Filippo Egalini, Ornella Guardamagna, Giulia Gaggero, et al.
Nutrients (2023) Vol. 15, Iss. 12, pp. 2672-2672
Open Access | Times Cited: 26
Do patients benefit from omega-3 fatty acids?
Samuel Sherratt, R. Preston Mason, Peter Libby, et al.
Cardiovascular Research (2023) Vol. 119, Iss. 18, pp. 2884-2901
Open Access | Times Cited: 26
Omega-3 fatty acids for cardiovascular event lowering
Gurleen Kaur, R. Preston Mason, Philippe Gabríel Steg, et al.
European Journal of Preventive Cardiology (2024) Vol. 31, Iss. 8, pp. 1005-1014
Open Access | Times Cited: 15
Impact of dietary n-6/n-3 fatty acid ratio of atherosclerosis risk: A review
Min‐Jie Cao, Fangwei Yang, David Julian McClements, et al.
Progress in Lipid Research (2024) Vol. 95, pp. 101289-101289
Closed Access | Times Cited: 13
Omega-3 fatty acids in primary and secondary prevention of cardiovascular diseases
Austin Tutor, Evan L. O’Keefe, Carl J. Lavie, et al.
Progress in Cardiovascular Diseases (2024)
Closed Access | Times Cited: 10
Involvement of Fatty Acids and Their Metabolites in the Development of Inflammation in Atherosclerosis
Stanislav Kotlyarov, Anna Kotlyarova
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1308-1308
Open Access | Times Cited: 38
Roles of Reactive Oxygen Species in Vascular Complications of Diabetes: Therapeutic Properties of Medicinal Plants and Food
Yi Tan, Meng Sam Cheong, Wai San Cheang
Oxygen (2022) Vol. 2, Iss. 3, pp. 246-268
Open Access | Times Cited: 36
Treatment With Icosapent Ethyl to Reduce Ischemic Events in Patients With Prior Percutaneous Coronary Intervention: Insights From REDUCE‐IT PCI
Benjamin E. Peterson, Deepak L. Bhatt, Philippe Gabríel Steg, et al.
Journal of the American Heart Association (2022) Vol. 11, Iss. 6
Open Access | Times Cited: 35
Vegan nutrition: a preliminary guide for health professionals
Christian Koeder, Federico J.A. Pérez-Cueto
Critical Reviews in Food Science and Nutrition (2022) Vol. 64, Iss. 3, pp. 670-707
Closed Access | Times Cited: 34
Fatty acids act on vascular endothelial cells and influence the development of cardiovascular disease
Kazuo Yamagata
Prostaglandins & Other Lipid Mediators (2023) Vol. 165, pp. 106704-106704
Closed Access | Times Cited: 20
Eicosapentaenoic Acid Improves Endothelial Nitric Oxide Bioavailability Via Changes in Protein Expression During Inflammation
Samuel Sherratt, Peter Libby, Hazem Dawoud, et al.
Journal of the American Heart Association (2024) Vol. 13, Iss. 14
Open Access | Times Cited: 6
Immune Function of Endothelial Cells: Evolutionary Aspects, Molecular Biology and Role in Atherogenesis
Stanislav Kotlyarov
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 9770-9770
Open Access | Times Cited: 28
A biological rationale for the disparate effects of omega-3 fatty acids on cardiovascular disease outcomes
Samuel Sherratt, Peter Libby, Deepak L. Bhatt, et al.
Prostaglandins Leukotrienes and Essential Fatty Acids (2022) Vol. 182, pp. 102450-102450
Open Access | Times Cited: 26
Omega-3 and cardiovascular prevention – Is this still a choice?
Massimiliano Ruscica, Cesare R. Sirtori, Stefano Carugo, et al.
Pharmacological Research (2022) Vol. 182, pp. 106342-106342
Open Access | Times Cited: 23
Omega-3-fatty acids: Do they prevent cardiovascular disease?
R. Preston Mason, Samuel Sherratt, Robert H. Eckel
Best Practice & Research Clinical Endocrinology & Metabolism (2022) Vol. 37, Iss. 3, pp. 101681-101681
Open Access | Times Cited: 21
Eicosapentaenoic acid (EPA) reduces pulmonary endothelial dysfunction and inflammation due to changes in protein expression during exposure to particulate matter air pollution
Samuel Sherratt, Peter Libby, Hazem Dawoud, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 162, pp. 114629-114629
Open Access | Times Cited: 13
Long‐term fasting induces a remodelling of fatty acid composition in erythrocyte membranes
Katharina Gewecke, Franziska Grundler, Massimiliano Ruscica, et al.
European Journal of Clinical Investigation (2025)
Open Access
Exploring neutrophils as therapeutic targets in cardiometabolic diseases
Mattia Albiero, Andrea Baragetti
Trends in Pharmacological Sciences (2025)
Closed Access
Potential effects of icosapent ethyl on cardiovascular outcomes in cigarette smokers: REDUCE-IT smoking
Michael Miller, Deepak L. Bhatt, Philippe Gabríel Steg, et al.
European Heart Journal - Cardiovascular Pharmacotherapy (2022) Vol. 9, Iss. 2, pp. 129-137
Open Access | Times Cited: 16
Efficacy and Safety of Omega-3 Fatty Acids in the Prevention of Cardiovascular Disease: A Systematic Review and Meta-analysis
Jie Yan, Ming Liu, Danning Yang, et al.
Cardiovascular Drugs and Therapy (2022) Vol. 38, Iss. 4, pp. 799-817
Closed Access | Times Cited: 15
The role of eicosapentaenoic acid in reducing important cardiovascular events, including coronary revascularization
Ram D. Bhatt, Peter Libby, Subodh Verma, et al.
Progress in Cardiovascular Diseases (2021) Vol. 69, pp. 3-10
Closed Access | Times Cited: 18
Controversies in the Use of Omega-3 Fatty Acids to Prevent Atherosclerosis
Renato Quispe, Abdulhamied Alfaddagh, Brigitte Kazzi, et al.
Current Atherosclerosis Reports (2022) Vol. 24, Iss. 7, pp. 571-581
Closed Access | Times Cited: 14
Differentiating EPA from EPA/DHA in cardiovascular risk reduction
Peter P. Tóth, M. John Chapman, Klaus G. Parhofer, et al.
American Heart Journal Plus Cardiology Research and Practice (2022) Vol. 17, pp. 100148-100148
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top